May 4, 2017
CTI BioPharma reports $19.8M loss
CTI BioPharma has reported net loss of $19.8 million for the first quarter of 2017. The loss is decrease compared to the profit of $3.3 million for the same period in 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
May 4, 2017
Sobi welcomes new CEO
Swedish Orphan Biovitrum (Sobi) has appointed Guido Oelkers as President and Chief Executive Officer effective as of 22 May 2017, succeeding Geoffrey McDonough.
May 3, 2017
Novo Nordisk reports 10% profit increase for Q1 2017
Novo Nordisk has reported profit of €1.4 billion for the first quarter of 2017, which is increase of 10%.
May 3, 2017
Sobi with new haemophilia research office in Greece
Swedish Orphan Biovitrum (Sobi) will open a new office in Athens, Greece.
April 27, 2017
South Korea fines Novartis $49 million over kickbacks, suspends insurance payment
South Korea said on Thursday it has fined Swiss drugmaker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to recommend the company’s drugs, and also suspended insurance coverage for some of its drugs.
April 27, 2017
Drugs firms call for phased transition of regulation after Brexit
Pharmaceutical companies called on Thursday for a phased transition in drug regulation after Britain leaves the European Union, in order to avoid supply disruption and protect public health.
April 27, 2017
Bayer reports 38% higher profit in Q1 2017
Bayer has reported net income of €2.083 million for Q1 2017 which is 37.9 percent higher comparing the same period last year.
April 27, 2017
BASF profit €322M up in Q1 2017
BASF, a Germany based chemical company has reported results for Q1 2017.
April 24, 2017
Bayer parners up with Goodbye Malaria to end malaria
Bayer has partnered up with Goodbye Malaria to support the objectives of Ending Malaria for Good in Southern Africa.
April 24, 2017
Stada welcomes new managing director
STADA Arzneimittel AG has appointed Dr. Ralph Grobecker as Managing Director at STADA GmbH.